Cargando…
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
MERS-CoV seronegative and seropositive camels received a single intramuscular dose of ChAdOx1 MERS, a replication-deficient adenoviral vectored vaccine expressing MERS-CoV spike protein, with further groups receiving control vaccinations. Infectious camels with active naturally acquired MERS-CoV inf...
Autores principales: | Alharbi, Naif Khalaf, Qasim, Ibrahim, Almasoud, Abdulrahman, Aljami, Haya A., Alenazi, Mohamed W., Alhafufi, Ali, Aldibasi, Omar S., Hashem, Anwar M., Kasem, Samy, Albrahim, Raed, Aldubaib, Musaad, Almansour, Ali, Temperton, Nigel J., Kupke, Alexandra, Becker, Stephan, Abu-obaidah, Ali, Alkarar, Ali, Yoon, In-Kyu, Azhar, Esam, Lambe, Teresa, Bayoumi, Faisal, Aldowerij, Ali, Ibrahim, Osman H., Gilbert, Sarah C., Balkhy, Hanan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6841732/ https://www.ncbi.nlm.nih.gov/pubmed/31705137 http://dx.doi.org/10.1038/s41598-019-52730-4 |
Ejemplares similares
-
Challenge infection model for MERS-CoV based on naturally infected camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2020) -
High Rate of Circulating MERS-CoV in Dromedary Camels at Slaughterhouses in Riyadh, 2019
por: Aljasim, Taibah A., et al.
Publicado: (2020) -
Transcriptomic Profiling of Dromedary Camels Immunised with a MERS Vaccine Candidate
por: Hala, Sharif, et al.
Publicado: (2021) -
The prevalence of Middle East respiratory Syndrome coronavirus (MERS-CoV) infection in livestock and temporal relation to locations and seasons
por: Kasem, Samy, et al.
Publicado: (2018) -
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
por: Bosaeed, Mohammad, et al.
Publicado: (2022)